Absolute Immature Platelet Counts Suggest Platelet Production Suppression during Complicated Relapsing Thrombotic...

Area of Science:

• Hematology
• Internal Medicine
• Clinical Diagnostics

Background:

• Thrombotic thrombocytopenic purpura (TTP) is a rare hematologic disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
• Absolute immature platelet counts (A-IPC) are increasingly recognized as a valuable marker for assessing thrombopoiesis and guiding treatment.
• Mycophenolate mofetil (MMF) and therapeutic plasma exchange (TPE) are used in managing TTP, but relapses can occur.

Observation:

• A patient with relapsing TTP on MMF maintenance therapy presented with a rapidly declining platelet count.
• Daily TPE was initiated, and MMF was discontinued. A-IPC and platelet counts were monitored closely.
• Initial transient improvement in A-IPC and platelet counts was followed by a significant decline, despite ongoing TPE.

Findings:

• The patient's A-IPC and platelet counts showed an initial increase after the first TPE, but subsequently decreased.
• ADAMTS13 activity remained critically low (<5%) with a detectable inhibitor, indicating ongoing disease activity.
• The pattern of initial improvement followed by a sharp decline in A-IPC suggested suppressed platelet production rather than effective TPE response.

Implications:

• A-IPC may serve as an early indicator of therapeutic response or lack thereof in TTP, potentially preceding changes in total platelet count.
• Monitoring A-IPC could help differentiate between effective treatment and suppressed platelet production in TTP patients.
• This case highlights the utility of A-IPC in managing complex TTP cases, especially those with relapses or suboptimal responses to standard therapies.